These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 17130575)

  • 1. Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol.
    Rickels MR; Liu C; Shlansky-Goldberg RD; Soleimanpour SA; Vivek K; Kamoun M; Min Z; Markmann E; Palangian M; Dalton-Bakes C; Fuller C; Chiou AJ; Barker CF; Luning Prak ET; Naji A
    Diabetes; 2013 Aug; 62(8):2890-7. PubMed ID: 23630300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term (4 years) improved insulin sensitivity following islet cell transplant in type 1 diabetes.
    Rydzon B; Monson RS; Oberholzer J; Varady KA; Bellin MD; Danielson KK
    Diabetes Metab Res Rev; 2018 Mar; 34(3):. PubMed ID: 29230944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early metabolic markers of islet allograft dysfunction.
    Baidal DA; Faradji RN; Messinger S; Froud T; Monroy K; Ricordi C; Alejandro R
    Transplantation; 2009 Mar; 87(5):689-97. PubMed ID: 19295313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the BETA-2 Score: An Improved Tool to Estimate Beta Cell Function After Clinical Islet Transplantation Using a Single Fasting Blood Sample.
    Forbes S; Oram RA; Smith A; Lam A; Olateju T; Imes S; Malcolm AJ; Shapiro AM; Senior PA
    Am J Transplant; 2016 Sep; 16(9):2704-13. PubMed ID: 27017888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR).
    Baidal DA; Ballou CM; Rickels MR; Berney T; Pattou F; Payne EH; Barton FB; Alejandro R;
    Diabetes Care; 2023 Apr; 46(4):697-703. PubMed ID: 36657975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who Should Be Considered for Islet Transplantation Alone?
    Othonos N; Choudhary P
    Curr Diab Rep; 2017 Apr; 17(4):23. PubMed ID: 28293906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human islet allotransplantation in 18 diabetic patients.
    Ricordi C; Tzakis A; Carroll P; Zeng Y; Rilo HL; Alejandro R; Shapiro R; Fung JJ; Demetris AJ; Bereiter DR
    Transplant Proc; 1992 Jun; 24(3):961. PubMed ID: 1604686
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.
    Kung HF; Lieberman BP; Zhuang ZP; Oya S; Kung MP; Choi SR; Poessl K; Blankemeyer E; Hou C; Skovronsky D; Kilbourn M
    Nucl Med Biol; 2008 Nov; 35(8):825-37. PubMed ID: 19026944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [End-stage nephropathy in type 1-diabetes mellitus - kidney transplantation alone or combined with islet or pancreas transplantation?].
    Lehman R; Gerber PA
    Ther Umsch; 2011 Dec; 68(12):699-706. PubMed ID: 22139985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategic opportunities in clinical islet transplantation.
    Shapiro AM; Lakey JR; Paty BW; Senior PA; Bigam DL; Ryan EA
    Transplantation; 2005 May; 79(10):1304-7. PubMed ID: 15912095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living donor islet transplantation, the alternative approach to overcome the obstacles limiting transplant.
    Iwanaga Y; Matsumoto S; Okitsu T; Noguchi H; Nagata H; Yonekawa Y; Yamada Y; Fukuda K; Tsukiyama K; Tanaka K
    Ann N Y Acad Sci; 2006 Oct; 1079():335-9. PubMed ID: 17130575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin independence of unstable diabetic patient after single living donor islet transplantation.
    Matsumoto S; Okitsu T; Iwanaga Y; Noguchi H; Nagata H; Yonekawa Y; Yamada Y; Nakai Y; Ueda M; Ishii A; Yabunaka E; Shapiro JA; Tanaka K
    Transplant Proc; 2005 Oct; 37(8):3427-9. PubMed ID: 16298617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
    Shapiro AM; Lakey JR; Ryan EA; Korbutt GS; Toth E; Warnock GL; Kneteman NM; Rajotte RV
    N Engl J Med; 2000 Jul; 343(4):230-8. PubMed ID: 10911004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes.
    Froud T; Baidal DA; Faradji R; Cure P; Mineo D; Selvaggi G; Kenyon NS; Ricordi C; Alejandro R
    Transplantation; 2008 Dec; 86(12):1695-701. PubMed ID: 19104407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation.
    Matsumoto S; Okitsu T; Iwanaga Y; Noguchi H; Nagata H; Yonekawa Y; Yamada Y; Fukuda K; Tsukiyama K; Suzuki H; Kawasaki Y; Shimodaira M; Matsuoka K; Shibata T; Kasai Y; Maekawa T; Shapiro J; Tanaka K
    Lancet; 2005 May 7-13; 365(9471):1642-4. PubMed ID: 15889479
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.